FDA Requests Comments on Proposed Collection of Information for Serological Tests in Blood Transfusion

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to the use of serological tests to reduce the risk of Trypanosoma cruzi infection in whole blood and blood components for transfusion, as part of the Paperwork Reduction Act of 1995 review process.